SiBionics develops non-invasive continuous glucose monitoring systems and AI-based retinal screening solutions to enhance chronic disease management. Their technology provides accurate blood glucose readings without finger pricks and assists in diagnosing eye diseases, addressing the critical need for accessible and efficient healthcare tools.
Funding
$71.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
SBFounders
Product
Problem
Managing chronic diseases like diabetes requires frequent and convenient monitoring, but traditional blood glucose meters rely on invasive finger pricks. Additionally, early detection of retinal diseases often requires specialized equipment and trained professionals, limiting accessibility and timely diagnosis.
Solution
SiBionics offers two primary solutions: a continuous glucose monitoring (CGM) system and an AI-powered retinal screening system. The CGM provides accurate blood glucose readings without the need for finger pricks, enhancing convenience and adherence for diabetic patients. The AI retinal screening system uses deep learning to assist in the diagnosis of various eye diseases, enabling earlier detection and intervention. Both systems aim to improve chronic disease management through innovative and accessible technology.
Target Audience
The primary target audience includes individuals with diabetes seeking convenient glucose monitoring, as well as healthcare professionals and institutions requiring efficient and accurate retinal screening tools.
Features
- **Silicon-Based Dynamic CGM:** A continuous glucose monitor that eliminates the need for finger prick calibration.
- **AI Retinal Screening System (爱昔瞳™):** AI-driven software for assisting in the diagnosis of retinal diseases.
- **Deep Learning Technology:** Utilizes advanced algorithms for image analysis and disease detection in retinal scans.
- Designed for both consumer and professional markets.